Trials / Completed
CompletedNCT04116632
A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults
A Multiple Dose Pharmacokinetic/Pharmacodynamic and Safety and Tolerability Study of BMS-963272 in Obese But Otherwise Healthy Adults
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study will assess the safety and tolerability of multiple doses of BMS-963272 in obese but otherwise healthy participants.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-963272 | Single dose with varying frequency among groups |
| DRUG | Placebo | Specified dose on specified days |
Timeline
- Start date
- 2019-09-30
- Primary completion
- 2020-02-10
- Completion
- 2020-02-10
- First posted
- 2019-10-04
- Last updated
- 2020-05-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04116632. Inclusion in this directory is not an endorsement.